Close Menu

NEW YORK (GenomeWeb) – Mesa Biotech announced today it has received 510(k) clearance and CLIA waiver from the US Food and Drug Administration for a test to detect and distinguish influenza A and B from nasal swab specimens. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.